Sema Sezin Göksu

6PUBLICATIONS
75CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Jul 24, 2025
Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study.

Mehmet Ali Nahit Sendur, Nuri Karadurmus, Irfan Cicin

|Jul 04, 2025
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study.

Serhat Sekmek, Hatice Bolek, Omer Faruk Kuzu

|Nov 28, 2023
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye.

Irfan Cicin, Nuri Karadurmus, Ahmet Bilici

|Jul 27, 2021
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.

Sema Sezgin Göksu, Ali Murat Tatlı, Çağlayan Geredeli

Pageof 1

Frequent Collaborators

4 joint publications

Mehmet Ali Sendur

3 joint publications

Nuri Karadurmus

2 joint publications

Irfan Cicin

2 joint publications

Ahmet Bilici